Gene-Disorder Association · Article
Gene
APOEApolipoprotein E
×
First reported
2001
Supporting publications
63
Manually curatedApproved treatment annotated
Association Review
In brief
The association between APOE (Apolipoprotein E) and Cardiovascular System Disease is reported, with clinical genetic testing available.
Sources
1
Clinical variants
0
Symptoms
0
Compounds
2
Trials
60of 1,132 via APOE compounds
Publications
63
01
At a glance
Association overview
A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.
Request access
02
Provenance
Evidence and sources
1 source
Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.
Request access
1 source summary
A gene summary alongside the source descriptions it was distilled from.
Request access
04
Cardiovascular System Disease
The disorder
7 database identifiers
The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).
Request access
05
Mechanism overlap
Shared mechanisms
1 shared pathway
Biological pathways and phenotype concepts shared by the gene and the disorder, with supporting publications.
Request access
06
Interventions
Therapeutics
2 compounds & drugs
Gene-targeting drugs and associated compounds, with class, approval status, mechanism, indications and trials.
Request access
07
Human studies
Clinical trials
1,132 clinical trials
Clinical trials reached through the pair’s compounds, keeping disorder-targeting trials separate from other indications.
Request access
63 publications
Publications linking the gene and the disorder, with title, authors, journal, year and citation metrics.
Request access
09
Provenance
References & sources
14 references
Every source and publication cited across this dossier, as one numbered reference list.
Request access